“…Copper signaling Prusiner, 1998;Klamt et al 2001;Brown, 2001;Martins et al, 2002;Wechselberger et al, 2002;Roucou & Leblanc, 2005;Toni et al, 2005;Brown, 2005 Bax pathway Roucou & Leblanc, 2005;Bounhar et al, 2001 Glatzel & Aguzzi, 2001;Prusiner, 1998 Transmissible Mink Encephalopathy Mink Prusiner, 1998;Glatzel & Aguzzi, 2001 Chronic Wasting Disease Deer and Elk Glatzel &Aguzzi, 2001;Prusiner, 1998 Feline spongiform encephalophaty Cats Glatzel &Aguzzi, 2001;Prusiner, 1998 Bovine spongiform encephalopathy (BSE) Cattle Glatzel &Aguzzi, 2001;Prusiner, 1998 Kuru Humans Prusiner, 1998;Glatzel & Aguzzi, 2001 CJD Humans Glatzel et al, 2005;Silva et al, 2003;Prusiner, 1998 Iatrogenic form of CJD Humans Glatzel & Aguzzi, 2001;Glatzel et al, 2005 Creutzfeldt-Jakob disease (nvCJD) Humans Glatzel &Aguzzi, 2001;Glatzel et al, 2005;Silva et al, 2003 Gerstmann-Sträussler-Scheinker Syndrome (GSS) Humans Glatzel et al, 2005;Prusiner, 1998 Fatal Familial Insomnia Humans Glatzel et al, 2005;Prusiner, 1998 cyte proliferation associated with neuronal loss and eventually to amyloid plaques of PrP sc (Silva et al, 2003). The incidence peak is around 55 to 65 years of age, as in Alzheimer and Parkinson diseases which also increase in incidence with age (Glatzel et al, 2005).…”